Business
CSL rules out making homegrown mRNA COVID vaccine – Sydney Morning Herald
The local biotech giant’s boss, Paul Perreault, says mRNA technology will be used to develop a treatment against flu instead…
The Australian Shareholders Association also whether the board had considered intervening in Mr Perreaults 2021 pay, after he received $61 million in total remuneration last year despite total shareholder return being zero. Mr McNamee said this total came…
Continue Reading
-
General18 hours agoMan dies in light plane crash north of Balranald in south-west NSW
-
Noosa News4 hours agoWoman hospitalised with life-threatening facial burns
-
General18 hours agoWhitewash at QUT | The Spectator Australia
-
Business19 hours agoInvest $5,000 into these ASX dividend stocks in August